MIRAL MAHESH PATEL to Follow-Up Studies
This is a "connection" page, showing publications MIRAL MAHESH PATEL has written about Follow-Up Studies.
Connection Strength
0.014
-
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study. Invest New Drugs. 2019 04; 37(2):345-351.
Score: 0.014